eFFECTOR Therapeutics Operations Inc

eFFECTOR Therapeutics Operations, Inc. develops small molecule drugs to selectively regulate protein synthesis. The Company offers technology, scientific approach in the discovery of selective translation regulators as a new class of therapeutics for cancer and other serious diseases.